CMS Budapest advised US medical technology company Becton Dickinson on its new plant opened at the Tatabánya industrial park, west of Budapest, following a HUF 6bn investment. The 10,500 square-meter plant will make immunology and cellular biology research reagents used for manufacturing medical products and it will reach full capacity in 2018 when it makes 8,000 different products.

The team assisting Becton Dickinson was led by Senior Associate András Klupács and Real Estate Partner Gábor Czike.


Events Calendar

Subscribe to Our Newsletter

Email Subscribe
First Name :(*)

Please let us know your name.

Last Name:(*)

Please enter your last name!

Your Email Address : (*)

Please let us know your email address.


Invalid Input

BCCH on Facebook

BCCH Latest Tweets

BCCH on Youtube

Apply for Membership

Becoming a member of our Chamber is simple, just fill out the online application form by clicking on the online application button below.

Please read our Charter carefully before submitting the application form. For further information on the key benefits of BCCH membership, please click here.


Online application

Corporate Plus Members